Search clinical trials for: Reference Values

Total 2375 results

Hoffmann-La Roche
Gilead Sciences; Seagen Inc.

Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (Morpheus-panBC)

Breast Cancer

Korea, Republic of, Spain, United States, Israel, United Kingdom, France, Australia, Germany
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; IRCCS Azienda... and other collaborators

Recruiting

The Italian REgistry of Pulmonary Non-tuberculous mycobactEria (IRENE)

Nontuberculous Mycobacteria

Italy
Hospices Civils de Lyon

Recruiting

Quality of Life in Patients Having a Prosthetic Joint Infection (QuaVIPA)

Quality of Life | Prosthetic Joint Infection

France
Genentech, Inc.

Recruiting

Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

Multiple Myeloma

United States, Canada, Spain, Australia
Hoffmann-La Roche

Recruiting

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

Neoplasms

Italy, France, Turkey, Korea, Republic of, Spain, China, United States, Hong Kong, Russian Federation, Poland
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST)

Non-Small Cell Lung Cancer

Canada, Belgium, Korea, Republic of, United States, France, Brazil, China, New Zealand, Israel, Spain, Argentina, Serbia, Mexico, Italy, Japan, Turkey, Taiwan, Costa Rica, Thailand, Australia, Germany, Hong Kong, Netherlands, Peru, Poland, Russian Federation and more
Ruggeri, Mirella

Recruiting

CBT-Eb Plus EMDR Versus CBT-Eb in Patients With Eating Disorders (TREAT-EMDR)

Eating Disorder

Italy
Hoffmann-La Roche

Recruiting

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Belgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
AiCuris Anti-infective Cures AG
Medpace, Inc.

Recruiting

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1)

HSV Infection

United States, Italy, Belgium, France, United Kingdom, Germany, Switzerland, Argentina, Australia, Georgia, Greece, Mexico, Israel, Canada
Imagine Institute
Reference center for rare diseases (Rare Gynecologic Diseases)

Recruiting

Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome (MRKH)

Mayer Rokitansky Kuster Hauser Syndrome

France
Hospices Civils de Lyon

Recruiting

Normal Values for Esophageal and Pyloric Impedance Planimetry Under General Anesthesia (NormaFLIP) (NormaFLIP)

Esophageal Dysfunction | Pylorus Dysfunction

France
Hospices Civils de Lyon

Recruiting

The French National Reference Centre of GTD (French GTDC)

Hydatidiform Mole | Gestational Trophoblastic Disease | Neoplasm, Trophoblastic | Hydatidiform Mole, Invasive

France
Lisette Nixon
Cancer Research UK

Recruiting

Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation (SCOPE2)

Oesophageal Cancer

United Kingdom
Lokon Pharma AB

Recruiting

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Pancreatic Cancer

United States
The University of Texas Health Science Center at...
Johns Hopkins University; M.D. Anderson Cancer Center; National Cancer Institute... and other collaborators

Recruiting

Prostate Cancer Upgrading Reference Set

Prostate Cancer

United States
Genentech, Inc.
Pfizer; Novartis Pharmaceuticals; Mylan Pharmaceuticals Inc; Sandoz; Roxane Laboratories and other collaborators

Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases

United States
Medical University of Graz
Amt der Steiermärkischen Landesregierung, Abteilung 3

Recruiting

Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols (CMR-TECH)

Healthy

Austria
National Institute on Deafness and Other Communication...

Recruiting

Normal Values in Hearing and Balance Testing

Healthy Volunteer

United States
Genentech, Inc.
Hoffmann-La Roche

Recruiting

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

Neoplasm Metastasis

Australia, Korea, Republic of, China, United States, Portugal, Brazil, Singapore, Spain, United Kingdom, Belgium, Austria, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, France, Germany, Hong Kong, Hungary, Israel, Italy, Japan, Me... and more
Cedars-Sinai Medical Center

Recruiting

Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

Healthy

United States
Genentech, Inc.

Active, not recruiting

To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

Breast Cancer | Solid Tumor

United States, France, Spain, United Kingdom, Canada
Hoffmann-La Roche

Active, not recruiting

A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation (CRISTALLO)

Chronic Lymphocytic Leukemia (CLL)

United States, Italy, Australia, Spain, France
Hoffmann-La Roche

Active, not recruiting

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

Rectal Cancer | Rectal Neoplasms

China
Hoffmann-La Roche

Active, not recruiting

A Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome

Angelman Syndrome

United States, Spain, Netherlands, Italy
Hoffmann-La Roche

Active, not recruiting

A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer (SKYSCRAPER-06)

Non-small Cell Lung Cancer (NSCLC)

United States, Korea, Republic of, Canada, Belgium, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Poland
Hoffmann-La Roche

Active, not recruiting

Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice (ORIGAMA)

Cancer

Spain, Germany, Switzerland, Austria, Australia
Organon and Co

Completed

A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

In Vitro Fertilization
Hoffmann-La Roche

Active, not recruiting

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Metastatic Colorectal Cancer

United States, Korea, Republic of, United Kingdom, Italy, Spain, Australia, Canada, Taiwan, Germany, Poland, Denmark
Hoffmann-La Roche

Active, not recruiting

A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS) (FENopta)

Relapsing Multiple Sclerosis

Czechia, Serbia, United States, Croatia, Bosnia and Herzegovina, Slovakia
Organon and Co

Completed

To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) (Ensure)

Infertility
Hoffmann-La Roche
PPD; Laboratory Corporation of America; Illingworth Research Group

Active, not recruiting

A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy (MINORE)

Multiple Sclerosis | Clinically Isolated Syndrome

United States, Spain, Switzerland, France, Germany
Hoffmann-La Roche

Active, not recruiting

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab (IMbrave251)

Unresectable Hepatocellular Carcinoma

Canada, Belgium, Korea, Republic of, Brazil, China, Croatia, Spain, Taiwan, Turkey, Italy, India, United Kingdom, Thailand, Costa Rica, Japan, France, Germany, Austria, Israel, Malaysia, Philippines, Estonia, Russian Federation, Greece, Bulgari... and more
Hoffmann-La Roche
PPD; Laboratory Corporation of America; Illingworth Research Group

Active, not recruiting

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab (SOPRANINO)

Multiple Sclerosis | Clinically Isolated Syndrome

United States, Spain, United Kingdom, Germany
Genentech, Inc.

Active, not recruiting

A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

Spain, Australia, United States
University of New Mexico
National Cancer Institute (NCI)

Active, not recruiting

Enhancing Prevention Pathways Toward Tribal Colorectal Health

Colorectal Neoplasm

United States
Agricultural University of Athens
Institute of Technology and Agricultural Products

Completed

Acute Glycemic Effects of Crackers Made by Different Flours

Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Agricultural University of Athens
Institute of Technology and Agricultural Products

Completed

Acute Effects of Fruit Juices Consumption on Postprandial Glycemic Responses and Satiety

Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Hoffmann-La Roche

Completed

A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder (ASD)

United States, Canada, Italy, Spain
Mental Health Services in the Capital Region, Denmark
Central Denmark Region; Mental Health Services in the North Denmark Region

Active, not recruiting

Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia". (FYF)

Psychotic Disorders | Schizophrenia and Related Disorders | Schizotypal Disorder | Schizophrenia Prodromal | Paranoid Schizophrenia | Paranoid Ideation | Paranoid Delusion | Ideas of Reference | Psychosis Paranoid | Psychotic Paranoia | Psychotic; Disorder, Delusional

Denmark
Hoffmann-La Roche

Active, not recruiting

A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Korea, Republic of, Argentina, Denmark, France, Spain, Brazil, United Kingdom, Turkey, Czechia, Thailand, Russian Federation, Italy, Poland, Taiwan, Singapore, Ukraine, Kenya, Hungary
Hoffmann-La Roche
GOG Foundation; European Network of Gynaecological Oncological Trial Groups...

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors (BOUQUET)

Ovarian Cancer

United States, Korea, Republic of, France, Germany, Spain, Italy, Canada, Russian Federation, United Kingdom, Turkey, Australia, Czechia, Switzerland
Hoffmann-La Roche

Active, not recruiting

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis (OLERO)

Multiple Sclerosis

United States, Spain, Austria, Czechia, Italy, Hungary, Australia, Portugal, Serbia, Canada, Germany, United Kingdom, Poland, Romania, Croatia, Israel, Belgium, Bulgaria, Estonia, Switzerland, Mexico, Lithuania, New Zealand, France, Slo... and more
Hoffmann-La Roche

Completed

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Carcinoma, Thymic

China
Agricultural University of Athens
Institute of Technology and Agricultural Products

Completed

Determining the Glycemic Effects of Sunflower Pasta

Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) (FENhance)

Relapsing Multiple Sclerosis

United States, Mexico, Hungary, China, Germany, Italy, Peru, Poland, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Tunisia, Netherlands, Argentina, Georgia, Hong Kong, Kenya, Dominican Republic, Finland, North Macedonia, Serb...
Hoffmann-La Roche

Active, not recruiting

A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

Diabetic Macular Edema

United Kingdom, Korea, Republic of, United States, Argentina, Poland, Puerto Rico, Israel, Spain, Canada
Hoffmann-La Roche
Chugai Pharmaceutical

Active, not recruiting

A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United States, Australia, Korea, Republic of, Brazil, China, Japan, Turkey, Taiwan, Argentina, Germany, Italy, Russian Federation, Spain, France, Netherlands, Poland, Canada, Denmark
Hoffmann-La Roche

Active, not recruiting

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis (Ocarina II)

Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis

Spain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
Hoffmann-La Roche

Active, not recruiting

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis

United States, Italy, Poland
Dompé Farmaceutici S.p.A

Completed

Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study) (NGF0121)

Dry Eye

United States, Italy

Search clinical trials for: Reference Values

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations